ArticleThe Journal of clinical investigation2018

An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion.

John D Klement et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.